Page last updated: 2024-12-05

methyl palmitate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Methyl palmitate is a naturally occurring ester found in palm oil and other plant oils. It is a colorless, odorless, and tasteless liquid at room temperature. Methyl palmitate is synthesized by esterification of palmitic acid with methanol. It is used as a food additive, a flavoring agent, and a lubricant. Methyl palmitate is also studied for its potential health benefits, such as its anti-inflammatory and antioxidant properties. It is important to note that the safety of methyl palmitate for human consumption is generally considered to be high. However, some studies have shown that it may have potential negative effects on liver function. More research is needed to fully understand the safety and efficacy of methyl palmitate.'

Cross-References

ID SourceID
PubMed CID8181
CHEMBL ID335125
CHEBI ID69187
SCHEMBL ID37365
MeSH IDM0071102

Synonyms (74)

Synonym
nsc-4197
metholene 2216
methyl palmitate ,
palmitic acid, methyl ester
112-39-0
palmitic acid methyl ester
methyl n-hexadecanoate
nsc4197
methyl hexadecanoate
hexadecanoic acid, methyl ester
n-hexadecanoic acid methyl ester
uniphat a60
methyl palmitate, >=97%
methyl palmitate, >=99% (capillary gc)
ai3-03509
einecs 203-966-3
hsdb 5570
nsc 4197
844D5088-5CCF-4B2D-A678-EA5A7E8CB149
hexadecanoic acid methyl ester (fame mix)
hexadecanoic acid methyl ester
CHEMBL335125
chebi:69187 ,
C16995
P0006
S0311
ec 203-966-3
unii-dpy8vcm98i
dpy8vcm98i ,
LMFA07010470
we(1:0/16:0)
dtxcid909149
dtxsid4029149 ,
cas-112-39-0
tox21_202768
NCGC00260315-01
BBL010507
AKOS005715213
S9383
STL146153
FT-0628772
dub pm cos
methyl palmitate [inci]
aec methyl palmitate
methyl palmitate [usp-rs]
methyl palmitate [hsdb]
SCHEMBL37365
palmitic methyl ester
radia 7120
emery 2216
HMS3650G09
mfcd00008994
formyl hexadecanoate
J-002763
methyl palmitate, analytical standard
CS-D1457
methyl palmitate, united states pharmacopeia (usp) reference standard
hexadecanoic acid-methyl ester
methyl hexadecanoate; hexadecanoic acid methyl ester
c16 fame
methyl palmitic acid
hexadecanoate methyl ester
methyl hexadecanoic acid
HY-N1482
SR-01000946783-1
sr-01000946783
Q16676086
AMY40844
CCG-267168
a methylhexadecanoic acid
D70331
tert-butyl3-(n-hydroxycarbamimidoyl)piperidine-1-carboxylate
EN300-18532402
methyl palmitate (usp-rs)

Research Excerpts

Overview

Methyl palmitate (MP) is a fatty acid methyl ester. MP is an effective Kupffer cell inhibitor.

ExcerptReferenceRelevance
"Methyl palmitate (MP) is a fatty acid methyl ester. "( Methyl palmitate modulates the nicotine-induced increase in basilar arterial blood flow.
Chun-Kai, H; Hsi-Hsien, C; Kuo-Feng, H; Shang-Jen, C; Shei-Dei Stephen, Y, 2021
)
3.51
"Methyl palmitate (MP) is an effective Kupffer cell inhibitor."( Methyl palmitate prevents CCl(4)-induced liver fibrosis.
Galicia-Moreno, M; Moreno, MG; Muriel, P; Reyes-Gordillo, K; Rodríguez-Rivera, A; Segovia, J; Shibayama, M; Tsutsumi, V; Vergara, P, 2008
)
2.51

Effects

Methyl palmitate (MP) has demonstrated marked hepato-, cardio- and pulmonary protective features. Its effects on ethanol-induced gastric injury have not been studied. MP has been shown to inhibit Kupffer cells and rat peritoneal macrophages.

ExcerptReferenceRelevance
"Methyl palmitate (MP) has been shown to diminish the nicotine-induced increase in blood flow in the brainstem."( Methyl Palmitate Modulated NMDA-Induced Cerebral Hyperemia in Hypertensive Rats.
Chang, HH; Chang, SJ; Hsu, CK; Lim, LY; Shei-Dei Yang, S, 2023
)
3.07
"Methyl palmitate (MP) has demonstrated marked hepato-, cardio- and pulmonary protective features; however, its effects on ethanol-induced gastric injury have not been studied."( Targeting MAPKs, NF-κB, and PI3K/AKT pathways by methyl palmitate ameliorates ethanol-induced gastric mucosal injury in rats.
Arab, HH; Eid, AH; Kabel, AM; Salama, SA; Shahin, NN, 2019
)
1.49
"Methyl palmitate (MP) has been shown earlier to inhibit Kupffer cells and rat peritoneal macrophages. "( Anti-inflammatory and antifibrotic effects of methyl palmitate.
El-Demerdash, E, 2011
)
2.07

Actions

Methyl palmitate failed to inhibit oxytocin- or KCl-induced contractions over the concentration range tested. It is thought to cause relaxation in vascular smooth muscle by opening voltage-activated potassium channels.

ExcerptReferenceRelevance
"Methyl palmitate is thought to cause relaxation in vascular smooth muscle by opening voltage-activated potassium channels. "( The effects of methyl palmitate, a putative regulator from perivascular fat, on the contractility of pregnant human myometrium.
Crankshaw, DJ; Morrison, JJ; Walsh, JM, 2014
)
2.2
"Methyl palmitate failed to inhibit oxytocin- or KCl-induced contractions over the concentration range tested. "( The effects of methyl palmitate, a putative regulator from perivascular fat, on the contractility of pregnant human myometrium.
Crankshaw, DJ; Morrison, JJ; Walsh, JM, 2014
)
2.2

Treatment

Methyl palmitate attenuated silica-induced lung inflammation and fibrosis. It significantly decreased lactate dehydrogenase (LDH) activity and the accumulation of the inflammatory cells in the bronchoalveolar lavage fluid (BALF)

ExcerptReferenceRelevance
"Methyl palmitate pretreatment significantly attenuated LPS-induced pulmonary histopathologic changes, alveolar hemorrhage, and neutrophil infiltration. "( Methyl palmitate attenuates lipopolysaccharide-induced acute lung injury in mice.
Acar, T; Aksun, S; Can, C; Gulaydin, A; Intepe, YS; Kalemci, S; Sütçü, R; Uner, AG; Yaylali, A; Zeybek, A, 2013
)
3.28
"Methyl palmitate-treated glucan injected mice were not protected against E."( Immunotherapeutic modification of Escherichia coli--induced experimental peritonitis and bacteremia by glucan.
Browder, IW; Di Luzio, NR; Williams, DL, 1983
)
0.99
"Treatment with methyl palmitate attenuated silica-induced lung inflammation and fibrosis, as it significantly decreased lactate dehydrogenase (LDH) activity and the accumulation of the inflammatory cells in the bronchoalveolar lavage fluid (BALF)."( Protective effects of methyl palmitate against silica-induced pulmonary fibrosis in rats.
Ammar, el-SM; El-Agamy, DS; Shalaby, AA; Sharawy, MH, 2013
)
1.04
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
fatty acid methyl esterA fatty acid ester that is the carboxylic ester obtained by the formal condensation of a fatty acid with methanol.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency0.05780.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency1.46390.000229.305416,493.5996AID743075
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (9)

Assay IDTitleYearJournalArticle
AID265881Inhibition of post acid activity of yeast 20S proteasome at 80 uM2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Development of lipopeptides for inhibiting 20S proteasomes.
AID49693Binding affinity against human CB2 receptor by using CHO-hCB2 transfected cell membrane [3H]WIN-55212-2 as radioligand at 10 uM2003Journal of medicinal chemistry, Oct-09, Volume: 46, Issue:21
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.
AID265879Inhibition of trypsin like activity of yeast 20S proteasome at 80 uM2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Development of lipopeptides for inhibiting 20S proteasomes.
AID144076Compound was tested for the inhibition of N-palmitoylethanolamine-selective acid amidase (NPAA) from rat lung homogenates at 100 uM2003Journal of medicinal chemistry, Oct-09, Volume: 46, Issue:21
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.
AID265877Inhibition of chymotrypsin like activity of yeast 20S proteasome at 80 uM2006Bioorganic & medicinal chemistry letters, Jun-15, Volume: 16, Issue:12
Development of lipopeptides for inhibiting 20S proteasomes.
AID71471Inhibition of fatty acid amide hydrolase (FAAH) from rat brain homogenates at 10 uM2003Journal of medicinal chemistry, Oct-09, Volume: 46, Issue:21
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.
AID49294Binding affinity against human Cannabinoid receptor 1 using CHO-hCB1 transfected cell membrane and [3H]CP-55940 as radioligand at 10 uM2003Journal of medicinal chemistry, Oct-09, Volume: 46, Issue:21
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.
AID1659751Agonist activity at TRPA1 (unknown origin) at 1000 uM relative to AITC2020Bioorganic & medicinal chemistry letters, 06-01, Volume: 30, Issue:11
Identification of a new class of non-electrophilic TRPA1 agonists by a structure-based virtual screening approach.
AID71472Inhibition of fatty acid amide hydrolase (FAAH) from rat brain homogenates at 100 uM2003Journal of medicinal chemistry, Oct-09, Volume: 46, Issue:21
Esters, retroesters, and a retroamide of palmitic acid: pool for the first selective inhibitors of N-palmitoylethanolamine-selective acid amidase.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (99)

TimeframeStudies, This Drug (%)All Drugs %
pre-199014 (14.14)18.7374
1990's23 (23.23)18.2507
2000's19 (19.19)29.6817
2010's28 (28.28)24.3611
2020's15 (15.15)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 49.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index49.31 (24.57)
Research Supply Index4.62 (2.92)
Research Growth Index4.82 (4.65)
Search Engine Demand Index76.36 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (49.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (1.98%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other99 (98.02%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]